<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KCV32QR" height="0" width="0" style="display:none;visibility:hidden">
Free access

Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells.

March 1, 1990
87 (6) 2314-2318

Abstract

Somatic cell hybrids between MCF-7 human breast cancer cells and normal immortalized human mammary epithelial cells have been obtained by polyethylene glycol-mediated cell fusion. The hybrid cells are suppressed in their ability to form tumors in nude mice, as well as in traits specific to the tumorigenic MCF-7 parent: growth factor independence, tumor necrosis factor sensitivity, and pS2 gene expression. In addition, they display other characteristics of the "normal" parent, including increased expression relative to the MCF-7 cells of the genes for the extracellular matrix component fibronectin, the intermediate filament keratin 5, and the angiogenesis inhibitor thrombospondin. The levels of keratins 8 and 18 also resemble those of the nontumorigenic parent. These results provide evidence for the existence of tumor suppressor gene products in immortal mammary epithelial cells. We propose a characteristic "suppressed" tumor cell phenotype, which encompasses altered cytoarchitecture, angiogenesis capabilities, and growth factor requirements.

Continue Reading

Information & Authors

Information

Published in

Go to Proceedings of the National Academy of Sciences
Go to Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences
Vol. 87 | No. 6
March 15, 1990
PubMed: 1690427

Classifications

    Submission history

    Published online: March 1, 1990
    Published in issue: March 15, 1990

    Authors

    Affiliations

    D A Zajchowski
    Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
    V Band
    Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
    D K Trask
    Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
    D Kling
    Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
    J L Connolly
    Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
    R Sager
    Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.

    Metrics & Citations

    Metrics

    Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


    Citation statements

    Altmetrics

    Citations

    If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

    Cited by

      Loading...

      View Options

      View options

      PDF format

      Download this article as a PDF file

      DOWNLOAD PDF

      Get Access

      Login options

      Check if you have access through your login credentials or your institution to get full access on this article.

      Personal login Institutional Login

      Recommend to a librarian

      Recommend PNAS to a Librarian

      Purchase options

      Purchase this article to get full access to it.

      Single Article Purchase

      Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells.
      Proceedings of the National Academy of Sciences
      • Vol. 87
      • No. 6

      Media

      Figures

      Tables

      Other

      Share

      Share

      Share article link

      Share on social media